Neudle.com: carbonic anhydrase inhibitor

Differential
(Click to cross reference)

abducens nerve paralysis

abducens nerve paralysis, bilateral

acetazolamide

adverse drug reaction

alcohol

antibodies to voltage-gated calcium channels

anticonvulsants, untoward effects of

benign essential tremor

blind spot, enlarged

calcium, serum

carbonic anhydrase inhibitor

CAT scan

cerebellar ataxia, children

cerebral cortical atrophy

cerebrospinal fluid, childhood

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, pressure increased

channelopathy

children

chloride channel dysfunction

chromosomal abnormality

cisternogram, radionuclide

coma

coma, episodic

complications

controversies in neurology

cranial nerve palsies

dementia

dichlorphenamide

dieting

differential diagnosis

down-beat nystagmus, primary position of gaze

drop attacks

dural sinus stenosis

dural sinus thrombosis

electroencephalogram, abnormalities of

electromyogram

emergencies, neurologic

episodic neurologic deficits

exercise

eye movement, disorders of

facial nerve palsy

familial

familial periodic ataxia

fatigue

fundus, abnormality of

gender

gene mutation

genetic neurologic disorders

genetic testing

glucagon-like peptide-1

headache, treatment of

hydrocephalus

hydrocephalus, normal pressure

hydrocephalus, treatment of

hyperkalemic periodic paralysis

hyperphosphatasia

hypocalcemia

hypokalemia

hypokalemic periodic paralysis

iatrogenic neurologic disorders

imbalance

incoordination

intracranial hypertension, benign

intracranial hypertension, benign, differential diagnosis

intracranial hypertension, benign, pathogenesis of

intracranial hypertension, benign, without papilledema

intracranial pressure, increased

intracranial pressure, increased, treatment of

intraocular pressure, increase

juvenile myoclonus epilepsy

migraine, aura of, status

migraine, intractable

migraine, treatment of

molecular genetics

MRI

MRI, abnormal

muscle diseases, characteristics of

muscle weakness

muscle weakness, causes of

muscle weakness, sudden onset of

myokymia

myotonia

myotonia congenita

myotonia, treatment of

nausea and vomiting

neurologic disease, diagnoses of

neuromyotonia

neuroophthalmology

nystagmus

nystagmus, hereditary

optic nerve sheath fenestration

optic nerve, decompression of

optic nerve, enlarged

osteomalacia

papilledema

paramyotonia congenita

paresthesias

paroxysmal neurologic deficits

perimetry

periodic paralysis

phenobarbital

potassium channel dysfunction

precipitating factors

pregnancy, neurologic complications in

primary episodic ataxia

prognosis

psychological testing, neurologic problems

shunt procedure, lumboperitoneal

shunt procedure, ventriculo-peritoneal

sodium channel dysfunction

transverse sinus stenosis

treatment of neurologic disorder

tremor

tremor, treatment of

trimethoprim-sulfamethoxazole

vertigo

vertigo, episodic

vertigo, migraine causing

vertigo, treatment of

vision, blurred

visual acuity, decreased

visual obscurations, transient

vitamin D

weight loss

weight management

Showing articles 850 to 880 of 880 << Previous

Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979

Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979

Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979

Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Diffuse"Anoxic"Myelopathy
Neurol 27:1049, Azzarelli,B.,et al, 1977

Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977

Pheniramine Aminosalicylate Overdosage:Reversal of Delirium & Choreiform Movements with Tacrine Treatment
Arch Neurol 34:313, Mendelson,G.,et al, 1977

Degeneration of Fasciculus Gracilis in Cystic Fibrosis
Neurol 27:185, Geller,A.,et al, 1977

Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Malabsorption of Pyridostigmine in Patients with Masthenia Gravis
Neurol 27:299, Cohan,S.L.,et al, 1977

Total Gaze Paresis in Amitriptyline Overdose
Neurol 27:695, Miadinich,E.K.,et al, 1977

Long-term Therapy of Myoclonus & Other Neurologic Disorders with L-5-Hydroxytryptophan & Carbidopa
NEJM 296:70, VanWoert,M.H.,et al, 1977

Postural Hypotension:Adrenergic Responsivity, & Levodopa Therapy
Neurol 27:921, Corder,C.N.,et al, 1977

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975

Neuropharmacological Aspects of Migraine
Editorial, BMJ 339, 1975, Aug., , 1975

Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974

Post-Herpes Zoster Neuralgia:Response to Vitamin E Therapy
Arch Dermatol 108:855, Ayres,S.Jr.,et al, 1973

The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973

Muscular Syndrome after Clofibrate
NEJM 286:1110, Katsilambros,N., 1972

Clofibrate for the Treatment of Occlusive CVD-Correspondence
NEJM 287:671, Hirsch,S.,et al, 1972

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970

Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969

Showing articles 850 to 880 of 880 << Previous